• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".

作者信息

Peyvandi Flora

机构信息

Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan.

出版信息

Haematologica. 2025 Jun 1;110(6):1443-1444. doi: 10.3324/haematol.2024.287163. Epub 2025 Jan 30.

DOI:10.3324/haematol.2024.287163
PMID:39882652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12130757/
Abstract
摘要

相似文献

1
More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".血栓性血小板减少性紫癜发病机制的更多探讨。对《未检测到抗ADAMTS13抗体的获得性血栓性血小板减少性紫癜：一种可能的潜在自身免疫机制》及《血栓性血小板减少性紫癜的不同表现》的评论
Haematologica. 2025 Jun 1;110(6):1443-1444. doi: 10.3324/haematol.2024.287163. Epub 2025 Jan 30.
2
The third form of thrombotic thrombocytopenic purpura shows up again: what is it, does it even exist, how to find out? Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".血栓性血小板减少性紫癜的第三种形式再次出现：它是什么，是否真的存在，如何查明？对《无可检测的抗ADAMTS13抗体的获得性血栓性血小板减少性紫癜：一种可能的潜在自身免疫机制》及《血栓性血小板减少性紫癜的不同表现》的评论
Haematologica. 2025 Jun 1;110(6):1445-1448. doi: 10.3324/haematol.2025.287535. Epub 2025 Feb 27.
3
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.儿童期和青少年期起病的获得性血栓性血小板减少性紫癜伴严重ADAMTS13缺乏症：法国全国血栓性微血管病登记处的一项队列研究
Lancet Haematol. 2016 Nov;3(11):e537-e546. doi: 10.1016/S2352-3026(16)30125-9. Epub 2016 Oct 3.
4
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.ADAMTS13和抗ADAMTS13抗体作为获得性血栓性血小板减少性紫癜缓解期复发的标志物。
Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26.
5
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.伴有严重ADAMTS13缺乏的成人期血栓性微血管病（血栓性血小板减少性紫癜）的流行病学和病理生理学：法国全国血栓性微血管病登记处的横断面分析
Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.
6
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.针对获得性特发性血栓性血小板减少性紫癜患者的 ADAMTS13 自身抗体靶向 ADAMTS13 的多个结构域。
Haematologica. 2010 Sep;95(9):1555-62. doi: 10.3324/haematol.2009.019299. Epub 2010 Apr 7.
7
Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.获得性血栓性血小板减少性紫癜无抗 ADAMTS13 抗体由甲型流感病毒 (H1N1) 成功治疗血浆置换：一例报告。
Am J Case Rep. 2021 Aug 2;22:e932251. doi: 10.12659/AJCR.932251.
8
Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura.人中性粒细胞肽和补体因子Bb在获得性血栓性血小板减少性紫癜发病机制中的作用
Haematologica. 2016 Nov;101(11):1319-1326. doi: 10.3324/haematol.2016.149021. Epub 2016 Aug 4.
9
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism.获得性血栓性血小板减少性紫癜，抗ADAMTS13抗体检测不到：一种可能的潜在自身免疫机制
Haematologica. 2025 Jun 1;110(6):1368-1372. doi: 10.3324/haematol.2024.285391. Epub 2024 Sep 26.
10
A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.一例以妊娠期血栓性血小板减少性紫癜为表现的严重ADAMTS13缺乏症病例。
Med Pregl. 2012 Sep-Oct;65(9-10):436-9. doi: 10.2298/mpns1210436n.

本文引用的文献

1
The different faces of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的不同表现。
Haematologica. 2025 Jun 1;110(6):1245-1247. doi: 10.3324/haematol.2024.286504. Epub 2024 Nov 14.
2
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism.获得性血栓性血小板减少性紫癜，抗ADAMTS13抗体检测不到：一种可能的潜在自身免疫机制
Haematologica. 2025 Jun 1;110(6):1368-1372. doi: 10.3324/haematol.2024.285391. Epub 2024 Sep 26.
3
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.米兰血栓性血小板减少性紫癜患者队列中接种SARS-CoV-2疫苗后的复发风险。
Haematologica. 2023 Nov 1;108(11):3152-3155. doi: 10.3324/haematol.2022.282478.
4
Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond.血栓性血小板减少性紫癜：从 1972 年到 2022 年及以后。
Semin Thromb Hemost. 2022 Nov;48(8):926-936. doi: 10.1055/s-0042-1749589. Epub 2022 Jul 6.
5
Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.获得性血栓性血小板减少性紫癜无抗 ADAMTS13 抗体由甲型流感病毒 (H1N1) 成功治疗血浆置换：一例报告。
Am J Case Rep. 2021 Aug 2;22:e932251. doi: 10.12659/AJCR.932251.
6
The ADAMTS13-von Willebrand factor axis in COVID-19 patients.新冠病毒感染患者中的ADAMTS13-血管性血友病因子轴
J Thromb Haemost. 2021 Feb;19(2):513-521. doi: 10.1111/jth.15191. Epub 2020 Dec 18.
7
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura.ISTH 血栓性血小板减少性紫癜诊断指南。
J Thromb Haemost. 2020 Oct;18(10):2486-2495. doi: 10.1111/jth.15006. Epub 2020 Sep 11.
8
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura.激活的 ADAMTS13，由抗体诱导，是亚临床免疫介导性血栓性血小板减少性紫癜的生物标志物。
Blood. 2020 Jul 16;136(3):353-361. doi: 10.1182/blood.2019004221.
9
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura.ADAMTS13特异性循环免疫复合物作为获得性血栓性血小板减少性紫癜患者复发的潜在预测指标。
Eur J Intern Med. 2017 Apr;39:79-83. doi: 10.1016/j.ejim.2016.11.003. Epub 2016 Nov 22.
10
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.血栓性血小板减少性紫癜及相关血栓性微血管病术语标准化的共识。
J Thromb Haemost. 2017 Feb;15(2):312-322. doi: 10.1111/jth.13571. Epub 2017 Jan 30.